Skip to main content
. 2025 Jun 21;17(13):2082. doi: 10.3390/cancers17132082
DC Dendritic cell
H&E Hematoxylin and eosin
iCCA Intrahepatic cholangiocarcinoma
ICI Immune checkpoint inhibitor
TIME Tumor immune microenvironment
TMB Tumor mutation burden